These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 10205625)

  • 1. Evaluation of the clearance characteristics of bioadhesive systems in humans.
    Soane RJ; Frier M; Perkins AC; Jones NS; Davis SS; Illum L
    Int J Pharm; 1999 Feb; 178(1):55-65. PubMed ID: 10205625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clearance characteristics of chitosan based formulations in the sheep nasal cavity.
    Soane RJ; Hinchcliffe M; Davis SS; Illum L
    Int J Pharm; 2001 Apr; 217(1-2):183-91. PubMed ID: 11292554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nasal route and drug delivery systems.
    Türker S; Onur E; Ozer Y
    Pharm World Sci; 2004 Jun; 26(3):137-42. PubMed ID: 15230360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioavailability enhancement of verapamil HCl via intranasal chitosan microspheres.
    Abdel Mouez M; Zaki NM; Mansour S; Geneidi AS
    Eur J Pharm Sci; 2014 Jan; 51():59-66. PubMed ID: 23999035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of bioadhesive polymers as delivery systems for nose to brain delivery: in vitro characterisation studies.
    Charlton ST; Davis SS; Illum L
    J Control Release; 2007 Apr; 118(2):225-34. PubMed ID: 17261340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chitosan based pentazocine microspheres for intranasal systemic delivery: development and biopharmaceutical evaluation.
    Sankar C; Rani M; Srivastava AK; Mishra B
    Pharmazie; 2001 Mar; 56(3):223-6. PubMed ID: 11265588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal delivery of morphine.
    Illum L; Watts P; Fisher AN; Hinchcliffe M; Norbury H; Jabbal-Gill I; Nankervis R; Davis SS
    J Pharmacol Exp Ther; 2002 Apr; 301(1):391-400. PubMed ID: 11907197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved nasal bioavailability of FITC-dextran (Mw 4300) from mucoadhesive microspheres in rabbits.
    El-Shafy MA; Kellaway IW; Taylor G; Dickinson PA
    J Drug Target; 2000; 7(5):355-61. PubMed ID: 10721797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the clearance characteristics of various microspheres in the human nose by gamma-scintigraphy.
    Tafaghodi M; Abolghasem Sajadi Tabassi S; Jaafari MR; Zakavi SR; Momen-Nejad M
    Int J Pharm; 2004 Aug; 280(1-2):125-35. PubMed ID: 15265553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and in vitro evaluations of gelatin A microspheres of ketorolac tromethamine for intranasal administration.
    Sankar C; Mishra B
    Acta Pharm; 2003 Jun; 53(2):101-10. PubMed ID: 14764244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and in vitro characterization of chitosan-based microspheres for nasal delivery of promethazine.
    Hafner A; Filipović-Grcić J; Voinovich D; Jalsenjak I
    Drug Dev Ind Pharm; 2007 Apr; 33(4):427-36. PubMed ID: 17523007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and gamma-scintigraphy study of Hibiscus rosasinensis polysaccharide-based microspheres for nasal drug delivery.
    Sharma N; Tyagi S; Gupta SK; Kulkarni GT; Bhatnagar A; Kumar N
    Drug Dev Ind Pharm; 2016 Nov; 42(11):1763-71. PubMed ID: 27032438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucoadhesive microspheres for nasal administration of an antiemetic drug, metoclopramide: in-vitro/ex-vivo studies.
    Gavini E; Rassu G; Sanna V; Cossu M; Giunchedi P
    J Pharm Pharmacol; 2005 Mar; 57(3):287-94. PubMed ID: 15807983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and bioadhesive properties of chitosan-ethylcellulose microspheres for nasal delivery.
    Martinac A; Filipović-Grcić J; Voinovich D; Perissutti B; Franceschinis E
    Int J Pharm; 2005 Mar; 291(1-2):69-77. PubMed ID: 15707733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution and clearance of bioadhesive formulations from the olfactory region in man: effect of polymer type and nasal delivery device.
    Charlton S; Jones NS; Davis SS; Illum L
    Eur J Pharm Sci; 2007 Mar; 30(3-4):295-302. PubMed ID: 17223022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal administration of melatonin starch microspheres.
    Mao S; Chen J; Wei Z; Liu H; Bi D
    Int J Pharm; 2004 Mar; 272(1-2):37-43. PubMed ID: 15019067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of degradable starch microspheres on the human nasal mucosa.
    Holmberg K; Björk E; Bake B; Edman P
    Rhinology; 1994 Jun; 32(2):74-7. PubMed ID: 7939145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preparation and properties of 5-fluorouracil-loaded chitosan microspheres for the intranasal administration].
    Zheng AP; Yu SY; Zhao Y; Wu FL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Jun; 36(3):300-4. PubMed ID: 15205705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal Delivery of Microspheres Loaded with 20 (R)-ginsenoside Rg3 Enhances Anti-Fatigue Effect in Mice.
    Zhang W; Wang X; Zhang M; Xu M; Tang W; Zhang Y; Lu L; Gao J; Gao S
    Curr Drug Deliv; 2017 Sep; 14(6):867-874. PubMed ID: 27834150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thermo-sensitive gels containing lorazepam microspheres for intranasal brain targeting.
    Jose S; Ansa CR; Cinu TA; Chacko AJ; Aleykutty NA; Ferreira SV; Souto EB
    Int J Pharm; 2013 Jan; 441(1-2):516-26. PubMed ID: 23147411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.